publication date: Jul. 27, 2012

Vol. 38, No. 30 –  FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin NCI Publishes FOA For Trials Network Program Download PDF

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.